Genotypic and phenotypic heterogeneity of African Americans with primary iron overload

Barton, 1995, Iron overload in African Americans, Am. J. Med., 99, 616, 10.1016/S0002-9343(99)80248-4 Wurapa, 1996, Primary iron overload in African Americans, Am. J. Med., 100, 9, 10.1016/S0002-9343(96)00053-8 Barton, 1995, Histochemically demonstrable hepatic iron excess in African Americans, Blood, 86, 128a Gordeuk, 1992, Iron overload in Africa. Interaction between a gene and dietary iron content, N. Engl. J. Med., 326, 95, 10.1056/NEJM199201093260204 Bloom, P.D., Burstein, G.R., Gordeuk, V.R., Iron overload in African Americans, in Barton, J.C., Edwards, C.Q., (Eds.). Hemochromatosis: Genetics, Pathophysiology, Diagnosis, and Treatment, Cambridge Univ. Press, Cambridge, pp. 475–484 Barton, 1997, Caucasian hemochromatosis (H) mutation Cys282Tyr in African American iron overload, J. Invest. Med., 45, 62a Barton, 2000, Iron overload in African Americans, 43 Monaghan, 1998, Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans, Am. J. Hematol., 58, 213, 10.1002/(SICI)1096-8652(199807)58:3<213::AID-AJH9>3.0.CO;2-U Barton, 2001, Inheritance of two HFE mutations in African Americans, Genet. Med., 3, 294, 10.1097/00125817-200107000-00005 Barton, 1996, Hemochromatosis, Blood Cells Mol. Dis., 22, 195, 10.1006/bcmd.1996.0100 Barton, 1996, D6S105 allele 8 (D6S105(8)) frequencies in African American iron overload (AAIO) probands, Caucasian hemochromatosis (H) probands, and normal control subjects from Alabama, Blood, 88, 490a Gordeuk V.R., Caleffi A., Corradini E., et al., Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin) gene, Blood Cells Mol. Dis. 31 (2003) 299–304 Beutler E., Barton J.C., Felitti V.J., et al., Ferroportin (SLC11A3) variant associated with iron overload in African-Americans, Blood Cells Mol. Dis. 31 (2003) 305–309 Barton, 2001, Primary iron overload in African Americans, J. Black Nurses Assoc., 12, 48 McLaren, 2003, Hemochromatosis and Iron Overload Screening (HEIRS) Study design for an evaluation of 100,000 primary care-based adults, Am. J. Med. Sci., 325, 53, 10.1097/00000441-200302000-00001 Bothwell, 1979, Clinical estimation of body iron stores, 88 Beutler, 1996, Mutation analysis in hereditary hemochromatosis, Blood Cells Mol. Dis., 22, 187, 10.1006/bcmd.1996.0027 Lee, 1998, The human Nramp2 gene, Blood Cells Mol. Dis., 24, 199, 10.1006/bcmd.1998.0186 Lee, 2001, A study of genes that may modulate the expression of hereditary hemochromatosis, Blood Cells Mol. Dis., 27, 783, 10.1006/bcmd.2001.0445 Acton, 2001, HFE mutations in African-American women with non-insulin-dependent diabetes mellitus, Ethnic. Dis., 11, 578 Rivers C.R. Chromosome 6p: Population and family studies of narcolepsy in the southeastern United States, Doctoral Dissertation, University of Alabama at Birmingham, 1999 Acton, 1993, Comparison of HLA phenotypes among African Americans from Alabama, Maryland and North Carolina, Transplant. Proc., 25, 2404 Edwards, 1988, Prevalence of hemochromatosis among 11,065 presumably healthy blood donors, N. Engl. J. Med., 318, 1355, 10.1056/NEJM198805263182103 Morrison, 2003, Factors associated with absence of advanced fibrosis among United States patients with phenotypic hereditary hemochromatosis, Ann. Intern. Med., 138, 634, 10.7326/0003-4819-138-8-200304150-00008 Barton, 1990, Management of hemochromatosis, Ann. Intern. Med., 129, 932, 10.7326/0003-4819-129-11_Part_2-199812011-00003 Barwick, 1985, Hb Long Island, Proc. Natl. Acad. Sci. USA, 82, 4602, 10.1073/pnas.82.14.4602 Schmidt R.M., Brosius E.M. Basic laboratory methods of hemoglobinopathy detection, Centers for Disease Control Publication 76–8266, U.S. Department of Health, Education, and Welfare, Atlanta, 1974 Betke, 1959, Estimation of small percentages of foetal haemoglobin, Nature, 184, 1877, 10.1038/1841877a0 Clegg, 1966, Abnormal hemoglobins, J. Mol. Biol., 19, 91, 10.1016/S0022-2836(66)80052-9 Tegos, 1980, A simplified method for studies of haemoglobin biosynthesis, Clin. Lab. Haematol., 2, 191, 10.1111/j.1365-2257.1980.tb00824.x Jandl, 1987, The hypochromic anemias and other disorders of iron metabolism, 181 D.J. Weatherall, D.J., The thalassemias, in: Beutler, E, Lichtman, M.A., Coller, B.S., Kipps, T.J., Seligsohn, U. (Eds.), Williams Hematology, 6th ed., McGraw–Hill, New York, 2001, pp. 547–580 Barton, 1997, Genetic and clinical description of hemochromatosis probands and heterozygotes, Blood Cells Mol. Dis., 23, 135, 10.1006/bcmd.1997.0129 Barton, 1999, Two novel missense HFE mutations (I105T and G93R) and confirmation of the S65C mutation in Alabama hemochromatosis probands, Blood Cells Mol. Dis., 25, 146, 10.1006/bcmd.1999.0240 Murphy, 1983, Population genetic analysis of insulin dependent diabetes mellitus using HLA allele frequencies, Clin. Genet., 23, 405, 10.1111/j.1399-0004.1983.tb01974.x Albert, 1984 Merryweather-Clarke, 1997, Global prevalence of putative haemochromatosis mutations, J. Med. Genet., 34, 275, 10.1136/jmg.34.4.275 Jeffery, 1999, Evidence from a Ghanian population of known African descent to support the proposition that hemochromatosis is a Caucasian disorder, Genet. Test, 3, 375, 10.1089/gte.1999.3.375 Beutler, 2000, The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic, Ann. Intern. Med., 133, 329, 10.7326/0003-4819-133-5-200009050-00008 Jazwinska, 1993, Localization of the hemochromatosis gene close to D6S105, Am. J. Hum. Genet., 53, 347 Worwood, 1994, Alleles at D6S265 and D6S105 define a haemochromatosis-specific genotype, Br. J. Haematol., 86, 863, 10.1111/j.1365-2141.1994.tb04843.x Kuffner, 2003, HLA class II and TNF genes in African Americans from the Southeastern United States, Hum. Immunol., 64, 639, 10.1016/S0198-8859(03)00056-9 Barton, 2000, Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload, Genet. Test., 4, 199, 10.1089/10906570050114911 Njajou, 2001, A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis, Nat. Genet., 28, 213, 10.1038/90038 Montosi, 2001, Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene, J. Clin. Invest., 108, 619, 10.1172/JCI200113468 Fleming, 2001, Ferroportin mutation in autosomal dominant hemochromatosis, J. Clin. Invest., 108, 521, 10.1172/JCI200113739 Njajou, 2002, The hemochromatosis N144H mutation of SLC11A3 gene in patients with type 2 diabetes, Mol. Genet. Metab., 75, 290, 10.1006/mgme.2002.3299 Devalia, 2002, Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3), Blood, 100, 695, 10.1182/blood-2001-11-0132 Roetto, 2002, A valine deletion of ferroportin 1, Blood, 100, 733, 10.1182/blood-2002-03-0693 Wallace, 2002, Novel mutation in ferroportin 1 is associated with autosomal dominant hemochromatosis, Blood, 100, 692, 10.1182/blood.V100.2.692 Njajou, 2002, Dominant hemochromatosis due to N144H mutation of SLC11A3, Blood Cells Mol. Dis., 29, 439, 10.1006/bcmd.2002.0581 Cazzola, 2002, Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3), Br. J. Haematol., 119, 539, 10.1046/j.1365-2141.2002.03946.x Bothwell, 1965, Idiopathic and Bantu hemochromatosis, Arch. Pathol., 79, 63 Camaschella, 2000, The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22, Nat. Genet., 25, 14, 10.1038/75534 Barton, 2001, Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload, Blood Cells Mol. Dis., 2, 279, 10.1006/bcmd.2001.0380 Lee, 2001, Mutation analysis of the transferrin receptor-2 gene in patients with iron overload, Blood Cells Mol. Dis., 27, 285, 10.1006/bcmd.2001.0381 Conrad, 1991, Sickle cell disease and hemochromatosis, Am. J. Hematol., 38, 150, 10.1002/ajh.2830380217 Castro, 1998, Hemochromatosis in a non-transfused African-American patient with sickle cell anemia, Blood, 92, 13b Hitender, 2000, A rare case report of hemochromatosis in an African-American female, Am. J. Gastroenterol., 95, 2580, 10.1111/j.1572-0241.2000.02941.x Beutler, 2001, The sickle cell diseases and related disorders, 581 Nicolas, 2002, Hepcidin, a new iron regulatory peptide, Blood Cells Mol. Dis., 29, 327, 10.1006/bcmd.2002.0573 Frazer, 2003, The orchestration of body iron intake, Blood Cells Mol. Dis., 30, 288, 10.1016/S1079-9796(03)00039-1 Mendenhall, 1993, Epidemiology of hepatitis C among veterans with alcoholic liver disease. The VA Cooperative Study Group 275, Am. J. Gastroenterol., 88, 1022 Alter, 1999, The prevalence of hepatitis C virus infection in the United States, 1988 through 1994, N. Engl. J. Med., 341, 556, 10.1056/NEJM199908193410802 Howell, 2000, Hepatitis C in African Americans, Gastroenterology, 119, 11385, 10.1053/gast.2000.19582 Batty, 2001, Hepatitis C virus seropositivity at the time of renal transplantation in the United States, Am. J. Transplant., 1, 179, 10.1034/j.1600-6143.2001.10213.x Friedman, 1990, Dietary iron overload in southern African rural blacks, Afr. Med. J., 78, 301 Jaskiewicz, 1995, Hepatocellular carcinoma in young patients, Anticancer Res., 15, 2723 Ioannou, 2003, Racial differences in the relationship between hepatitis C infection and iron stores, Hepatology, 37, 795, 10.1053/jhep.2003.50147 Gordeuk, 1986, Dietary iron overload persists in rural sub-Saharan Africa, Lancet, 1, 1310, 10.1016/S0140-6736(86)91230-4 Bothwell, 1979, Iron loading anemias, 175 Barton, 2000, Histochemistry of iron and iron-associated proteins in hemochromatosis, 200 Baynes, 2000, Interactions of alcohol, iron and hemochromatosis, 468